series-b
Stage
2
Investors
About
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing novel oral small molecule therapies that target STAT3 to treat fibrosis-driven, inflammatory, and proliferative diseases.
Explore Tvardi's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.